HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

40.620

-3.580-8.10%

Volume:18.78M

Turnover:777.40M

Market Cap:23.64B

PE:-9.07

High:44.500

Open:43.560

Low:40.260

Close:44.200

52wk High:80.900

52wk Low:29.980

Shares:582.00M

HK Float Shares:582.00M

Volume Ratio:1.02

T/O Rate:3.23%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-4.480

ROE:--

ROA:-11.83%

PB:6.67

PE(LYR):-9.07

PS:53.61

Loading ...

Overview Company News Filings

Insilico Medicine Cayman Topco - to Receive up to $18 Mln in Upfront and Near-Term Milestone Payments

THOMSON REUTERS

Movement Alert｜Insilico Medicine Falls 5.06% in Regular Trading, Massive Lock-Up Expiry Countdown Suppresses Rebound Momentum

Insilico Shares Surge Nearly 14% on Inclusion in Key China Index Series, Following Multiple Major Index Additions

Insilico Medicine's Stock Surges Over 6% Against Market Trend as Rentosertib Phase 3 Trial Meeting Commences

Movement Alert｜Insilico Medicine Rises 5.05% in Regular Trading, ISM8969 First-in-Human Dosing Milestone Catalyst Extends with Sector Tailwind

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven Nlrp3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration With Hygtia Therapeutics

THOMSON REUTERS

InSilico Medicine Completes First Human Dosing of Parkinson's Disease Drug in Phase 1 Trial

MT Newswires Live

INSILICO Shares Surge Over 6% in Morning Session Following First Patient Dosing Milestone for NLRP3 Inhibitor

Movement Alert｜Insilico Medicine Rises 5.17% in Regular Trading, ISM8969 Achieves First Clinical Milestone with First-in-Human Dosing

Key Hong Kong Market Announcements: Six Firms Launch IPOs, Yum China to Acquire Pizza Hut China for US$1.2 Billion

INSILICO and Hengtai Biotech Achieve First Clinical Milestone for Jointly Developed ISM8969, Dosing Initial Patient in Phase I Study

Insilico Medicine completes first patient dosing in Phase 1 trial of NLRP3 inhibitor ISM8969

Movement Alert｜Insilico Medicine Falls 5.1% in Regular Trading, Massive Lock-Up Expiry Countdown Resumes Pressure After Brief Index-Inclusion Rebound

BUZZ-InSilico jumps most in 3 weeks on inclusion in China Securities Index Series

Movement Alert｜Insilico Medicine Rises 5.61% in Regular Trading, Dual Index Inclusion Boosts Sentiment

INSILICO Added to Key China Securities Index Series

Movement Alert｜Insilico Medicine Falls 5.01% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Fundamental Weakness

Movement Alert｜Insilico Medicine Falls 5.09% in Regular Trading, Massive Lock-up Expiry Countdown Continues to Weigh on Share Price

Movement Alert｜Insilico Medicine Falls 5.43% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Life Sciences Sector Weakness

Movement Alert｜Insilico Medicine Falls 5.69% in Regular Trading, Massive Lock-up Expiry Approaching Amid Broad Sector Weakness

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/03696/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"03696","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"INSILICO","latestPrice":40.62,"timestamp":1787299688006,"preClose":44.2,"halted":0,"volume":18778893,"delay":0,"changeRate":-0.08099547511312229,"floatShares":582000000,"shares":582000000,"eps":-4.48,"marketStatus":"Not Yet Opened","change":-3.58,"latestTime":"08-21 16:08:08","open":43.56,"high":44.5,"low":40.26,"amount":777399663,"amplitude":0.095928,"askPrice":40.62,"askSize":2000,"bidPrice":40.6,"bidSize":10500,"shortable":3,"etf":0,"ttmEps":-4.707,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":44.2,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":1.0245156720310378,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03696\",,,,,undefined,":{"symbol":"03696","floatShares":582000000,"roa":"-11.83%","roe":"--","lyrEps":-4.48,"volumeRatio":1.0245156720310378,"shares":582000000,"dividePrice":0,"high":44.5,"amplitude":0.095928,"preClose":44.2,"low":40.26,"week52Low":29.98,"pbRate":"6.67","psRate":"53.61","week52High":80.9,"institutionHeld":0,"latestPrice":40.62,"committee":0.68,"eps":-4.48,"divideRate":0,"volume":18778893,"delay":0,"ttmEps":-4.707,"open":43.56,"prevYearClose":37.14,"prevWeekClose":44.56,"prevMonthClose":45.7,"prevQuarterClose":39.62,"fiveDayClose":44.56,"twentyDayClose":47.06,"sixtyDayClose":48.1,"earningDate":1787673600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03696\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-03-30","symbol":"03696","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03696\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03696\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1786032000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03696\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03696","date":"2026-08-21","current":-8.6297,"percent":0.853503,"low":-126.474328,"twenty":-93.349385,"median":-12.788902,"eighty":-8.725669,"high":-6.819055,"avg":-42.885428,"sd":42.328622,"marketCap":23250969240},"quantilePoints":[{"date":"2026-01-02","current":-60.518922,"twenty":-60.091977,"median":-54.070713,"eighty":-44.509914,"marketCap":20885577298},{"date":"2026-01-09","current":-75.603624,"twenty":-68.00457,"median":-60.518922,"eighty":-55.21804,"marketCap":26120865700},{"date":"2026-01-16","current":-88.730045,"twenty":-88.029114,"median":-68.708073,"eighty":-60.032461,"marketCap":30678123120},{"date":"2026-01-23","current":-103.197987,"twenty":-90.498742,"median":-83.671368,"eighty":-60.384368,"marketCap":35679909160},{"date":"2026-01-30","current":-103.586135,"twenty":-97.608242,"median":-87.528966,"eighty":-61.04227,"marketCap":35850899140},{"date":"2026-02-06","current":-102.242154,"twenty":-102.624487,"median":-88.730045,"eighty":-63.670801,"marketCap":35423424190},{"date":"2026-02-13","current":-120.862692,"twenty":-111.02361,"median":-93.674734,"eighty":-69.411577,"marketCap":41892545100},{"date":"2026-02-20","current":-120.573146,"twenty":-113.535701,"median":-95.532684,"eighty":-72.22559,"marketCap":41778551780},{"date":"2026-02-27","current":-101.790811,"twenty":-112.276672,"median":-99.165731,"eighty":-75.603624,"marketCap":35309430870},{"date":"2026-03-06","current":-91.269503,"twenty":-111.865913,"median":-96.698006,"eighty":-83.671368,"marketCap":31633146300},{"date":"2026-03-13","current":-90.695168,"twenty":-110.462075,"median":-97.855611,"eighty":-84.923636,"marketCap":31476674990},{"date":"2026-03-20","current":-90.217416,"twenty":-108.336494,"median":-95.132264,"eighty":-85.637602,"marketCap":31333988340},{"date":"2026-03-27","current":-94.081335,"twenty":-107.867915,"median":-93.382526,"eighty":-84.923636,"marketCap":32646705520},{"date":"2026-04-02","current":-11.868567,"twenty":-107.743793,"median":-93.151788,"eighty":-79.84609,"marketCap":32770014500},{"date":"2026-04-10","current":-12.877757,"twenty":-106.637664,"median":-92.691879,"eighty":-68.00457,"marketCap":35546164200},{"date":"2026-04-17","current":-12.624497,"twenty":-104.449464,"median":-91.076584,"eighty":-59.957423,"marketCap":34802041600},{"date":"2026-04-24","current":-14.676127,"twenty":-103.459526,"median":-89.747522,"eighty":-15.148699,"marketCap":40497441500},{"date":"2026-04-30","current":-13.071473,"twenty":-103.255287,"median":-88.68986,"eighty":-14.223075,"marketCap":36089946100},{"date":"2026-05-08","current":-13.340785,"twenty":-103.091175,"median":-88.574112,"eighty":-13.384736,"marketCap":36805448600},{"date":"2026-05-15","current":-10.983422,"twenty":-102.596106,"median":-86.723486,"eighty":-13.331626,"marketCap":30308685900},{"date":"2026-05-22","current":-10.451313,"twenty":-102.308283,"median":-85.637602,"eighty":-12.881328,"marketCap":28849060800},{"date":"2026-05-29","current":-8.622113,"twenty":-102.242154,"median":-83.671368,"eighty":-12.624497,"marketCap":23800475160},{"date":"2026-06-05","current":-7.875348,"twenty":-101.790811,"median":-78.255166,"eighty":-12.515704,"marketCap":21739827960},{"date":"2026-06-12","current":-7.01543,"twenty":-100.06892,"median":-65.190557,"eighty":-12.085532,"marketCap":19370083680},{"date":"2026-06-18","current":-7.947724,"twenty":-100.046598,"median":-60.518922,"eighty":-10.958896,"marketCap":21945892680},{"date":"2026-06-26","current":-7.919554,"twenty":-99.340788,"median":-54.070713,"eighty":-10.005367,"marketCap":21877204440},{"date":"2026-07-03","current":-7.743582,"twenty":-98.690073,"median":-27.191152,"eighty":-9.565807,"marketCap":21396386760},{"date":"2026-07-10","current":-8.877372,"twenty":-98.062553,"median":-14.676127,"eighty":-8.824583,"marketCap":24510253640},{"date":"2026-07-17","current":-8.953114,"twenty":-97.4013,"median":-14.167396,"eighty":-8.882012,"marketCap":24727766400},{"date":"2026-07-24","current":-9.751189,"twenty":-96.617922,"median":-13.560542,"eighty":-8.925911,"marketCap":26937238120},{"date":"2026-07-31","current":-9.466525,"twenty":-95.411086,"median":-13.340785,"eighty":-8.88656,"marketCap":26158771400},{"date":"2026-08-07","current":-9.410567,"twenty":-94.035578,"median":-13.201047,"eighty":-8.763781,"marketCap":26009946880},{"date":"2026-08-14","current":-9.225945,"twenty":-93.733176,"median":-12.895614,"eighty":-8.825762,"marketCap":25506233120},{"date":"2026-08-21","current":-8.414722,"twenty":-93.349385,"median":-12.788902,"eighty":-8.725669,"marketCap":23250969240}],"updateTime":1787504586052},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03696\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645043421","title":"Insilico Medicine Cayman Topco - to Receive up to $18 Mln in Upfront and Near-Term Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2645043421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645043421?lang=en_us&edition=fundamental","pubTime":"2026-06-22 12:26","pubTimestamp":1782102375,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S017:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111843548","title":"Movement Alert｜Insilico Medicine Falls 5.06% in Regular Trading, Massive Lock-Up Expiry Countdown Suppresses Rebound Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1111843548","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111843548?lang=en_us&edition=fundamental","pubTime":"2026-06-22 11:28","pubTimestamp":1782098896,"startTime":"0","endTime":"0","summary":"On June 22, Insilico Medicine fell 5.06% in regular trading, trading at HK$36.5/share, with turnover of HK$125 million.On the news front, despite the company being formally included in the FTSE...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155526283","title":"Insilico Shares Surge Nearly 14% on Inclusion in Key China Index Series, Following Multiple Major Index Additions","url":"https://stock-news.laohu8.com/highlight/detail?id=1155526283","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155526283?lang=en_us&edition=fundamental","pubTime":"2026-06-18 16:21","pubTimestamp":1781770884,"startTime":"0","endTime":"0","summary":"Shares of Insilico (03696) rose strongly against the broader market trend throughout the trading session. By the close, the stock had gained 13.84% to HK$38.34, with a turnover of HK$338 million.The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1141","BK4588","03696","IPOS","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102796039","title":"Insilico Medicine's Stock Surges Over 6% Against Market Trend as Rentosertib Phase 3 Trial Meeting Commences","url":"https://stock-news.laohu8.com/highlight/detail?id=1102796039","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102796039?lang=en_us&edition=fundamental","pubTime":"2026-06-18 10:34","pubTimestamp":1781750070,"startTime":"0","endTime":"0","summary":"Shares of Insilico Medicine (03696) rose more than 6% against the broader market trend. At the time of writing, the stock was up 6.65% to HK$35.92, with a turnover of HK$48.60 million. The catalyst...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","AGIX","03696","CHAT","ARTY","AIPO","BK1141","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113078048","title":"Movement Alert｜Insilico Medicine Rises 5.05% in Regular Trading, ISM8969 First-in-Human Dosing Milestone Catalyst Extends with Sector Tailwind","url":"https://stock-news.laohu8.com/highlight/detail?id=1113078048","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113078048?lang=en_us&edition=fundamental","pubTime":"2026-06-18 10:12","pubTimestamp":1781748765,"startTime":"0","endTime":"0","summary":"On June 18, Insilico Medicine rose 5.05% in regular trading, trading at HK$35.08/share, with turnover of HK$34.16 million.On the news front, the rally extends the positive momentum from the previous...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644749844","title":"Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven Nlrp3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration With Hygtia Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2644749844","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644749844?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:00","pubTimestamp":1781701204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA7DC6R1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644413718","title":"InSilico Medicine Completes First Human Dosing of Parkinson's Disease Drug in Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2644413718","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644413718?lang=en_us&edition=fundamental","pubTime":"2026-06-17 13:52","pubTimestamp":1781675530,"startTime":"0","endTime":"0","summary":"InSilico Medicine Cayman  completed first-in-human dosing in a phase 1 clinical trial of ISM8969, according to a Wednesday Hong Kong bourse filing.The oral NLRP3 inhibitor is being developed to treat chronic neuroinflammation and central nervous system disorders, including Parkinson's disease.The milestone marks the first clinical achievement under the company's co-development collaboration with Hygtia Therapeutics.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199395994","title":"INSILICO Shares Surge Over 6% in Morning Session Following First Patient Dosing Milestone for NLRP3 Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=1199395994","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199395994?lang=en_us&edition=fundamental","pubTime":"2026-06-17 10:14","pubTimestamp":1781662465,"startTime":"0","endTime":"0","summary":"Shares of INSILCO (03696) rose more than 6% during the morning trading session. At the time of writing, the stock was up 4.93% to HK$34.5, with a turnover of HK$21.1158 million. Key Development The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","03696","VXUS","BK4588","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103060181","title":"Movement Alert｜Insilico Medicine Rises 5.17% in Regular Trading, ISM8969 Achieves First Clinical Milestone with First-in-Human Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=1103060181","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103060181?lang=en_us&edition=fundamental","pubTime":"2026-06-17 09:58","pubTimestamp":1781661503,"startTime":"0","endTime":"0","summary":"On June 17, Insilico Medicine rose 5.17% in regular trading, trading at 34.62 HKD/share, with turnover of approximately 13.92 million HKD.On the news front, the company announced that ISM8969,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150986317","title":"Key Hong Kong Market Announcements: Six Firms Launch IPOs, Yum China to Acquire Pizza Hut China for US$1.2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1150986317","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150986317?lang=en_us&edition=fundamental","pubTime":"2026-06-17 09:26","pubTimestamp":1781659607,"startTime":"0","endTime":"0","summary":"Several new listings are commencing their public offerings in Hong Kong. Lingyi Itech(Guangdong)Company (HKEX: 01688) has initiated its share offering today, with cornerstone investors including GF...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0672654166.SGD","LU1023057109.AUD","LU0431992006.USD","LU0823426308.USD","BK1588","LU1267930573.SGD","LU2008162690.USD","BK0077","03696","HK0000320264.USD","IPOS","LU0359202008.SGD","LU0456842615.SGD","LU0594300419.USD","BK1100","IE0003895053.USD","LU0348825331.USD","BK4209","LU0310800379.SGD","BK1144","BK4585","BK0084","LU0228659784.USD","LU0320764755.SGD","02889","LU0543330483.HKD","BK0251","LU0708994859.HKD","BK1233","LU0128522157.USD","06675","IE0034224299.USD","LU0868486357.SGD","IE00BGV7N243.SGD","IE00B0JY6N72.USD","YUMC","09987","02252","LU1515016050.SGD","LU2279701549.SGD","LU0651946864.USD","LU0029875118.USD","LU0128525929.USD","BK4588","LU1051768304.USD","LU2177674079.SGD","BK1617","LU0572944931.SGD","HK0000306685.HKD","BK0132","BK0214","HK0000306701.USD","LU0327786744.USD","HK0000320223.HKD","LU0650527681.SGD","BK4526","BK0081","LU0823426480.USD","BK4504","LU0359201612.USD","VXUS","LU0417516902.SGD","LU0029864427.USD","002600","BK0028","BK4531","688630","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145575282","title":"INSILICO and Hengtai Biotech Achieve First Clinical Milestone for Jointly Developed ISM8969, Dosing Initial Patient in Phase I Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1145575282","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145575282?lang=en_us&edition=fundamental","pubTime":"2026-06-17 08:36","pubTimestamp":1781656586,"startTime":"0","endTime":"0","summary":"INSILICO (03696) announced that ISM8969, co-developed with Shenzhen Hengtai Biotechnology Co., Ltd. (Hengtai Biotech), has reached its first clinical milestone with the administration of the first...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644679699","title":"Insilico Medicine completes first patient dosing in Phase 1 trial of NLRP3 inhibitor ISM8969","url":"https://stock-news.laohu8.com/highlight/detail?id=2644679699","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644679699?lang=en_us&edition=fundamental","pubTime":"2026-06-17 08:00","pubTimestamp":1781654440,"startTime":"0","endTime":"0","summary":"Insilico Medicine Cayman Topco dosed the first participant in a Phase 1 study of ISM8969, an oral NLRP3 inhibitor developed with HengTai Bio.No clinical results have been presented; the announcement covers trial initiation and first-in-human dosing.The study is designed to assess safety and tolerability in healthy volunteers and obese adults with cardiovascular risk.Insilico granted HengTai Bio global rights to develop and commercialize ISM8969; the partners split worldwide economics 50%-50%.The deal includes up to USD 66 million in upfront and milestone payments to Insilico.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the regulat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL76jGx7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199143421","title":"Movement Alert｜Insilico Medicine Falls 5.1% in Regular Trading, Massive Lock-Up Expiry Countdown Resumes Pressure After Brief Index-Inclusion Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1199143421","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199143421?lang=en_us&edition=fundamental","pubTime":"2026-06-16 10:08","pubTimestamp":1781575721,"startTime":"0","endTime":"0","summary":"On June 16, Insilico Medicine fell 5.1% in regular trading, trading at 32.9 HKD/share, with turnover of approximately 18.11 million HKD. The decline erased most of the prior session's gains driven by...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643226457","title":"BUZZ-InSilico jumps most in 3 weeks on inclusion in China Securities Index Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2643226457","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643226457?lang=en_us&edition=fundamental","pubTime":"2026-06-15 10:07","pubTimestamp":1781489229,"startTime":"0","endTime":"0","summary":"BUZZ-InSilico jumps most in 3 weeks on inclusion in China Securities Index Series** Shares of InSilico Medicine Cayman TopCo 3696.HK jump  7.6% to HK$36.4, on course for biggest one-day pct gain since May 22** Stock of the AI-driven drug discovery and pipeline development group hits the highest level since June 9  ** Co says it has been included in China Securities Index Series, including CSI Hong Kong Connect Innovative Drug Index .CSI931250, CSI Hong Kong Brand Name Drug Index .CSI931787, and CSI HK Connect Health Care Composite Index .CSI930965, effective June 15** Inclusion expected to broaden co's exposure among international institutional investors and research analysts, attract capital inflows from passive funds tracking indexes, diversify shareholder base, and improve trading liquidity for its shares - co** YTD, stock down 5.1%, Hang Seng Biotech Index .HSBIO down 12.5%  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL1N42N01K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150477327","title":"Movement Alert｜Insilico Medicine Rises 5.61% in Regular Trading, Dual Index Inclusion Boosts Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1150477327","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150477327?lang=en_us&edition=fundamental","pubTime":"2026-06-15 09:46","pubTimestamp":1781487998,"startTime":"0","endTime":"0","summary":"On June 15, Insilico Medicine rose 5.61% in regular trading, trading at 36.36 HKD/share, with turnover of 31.75 million HKD.On the news front, the company was formally included in the CSI Index...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178074634","title":"INSILICO Added to Key China Securities Index Series","url":"https://stock-news.laohu8.com/highlight/detail?id=1178074634","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178074634?lang=en_us&edition=fundamental","pubTime":"2026-06-15 08:10","pubTimestamp":1781482226,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced its inclusion in several China Securities Index series. The company will be added to the CSI Hong Kong Stock Connect Innovative Drug Index (Code: 931250), the CSI Hong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165934834","title":"Movement Alert｜Insilico Medicine Falls 5.01% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Fundamental Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1165934834","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165934834?lang=en_us&edition=fundamental","pubTime":"2026-06-11 09:58","pubTimestamp":1781143111,"startTime":"0","endTime":"0","summary":"On June 11, Insilico Medicine fell 5.01% in regular trading, trading at 31.52 HKD/share, with trading volume of 24.78 million HKD. The decline marks the fourth consecutive session of over 5% losses...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185699673","title":"Movement Alert｜Insilico Medicine Falls 5.09% in Regular Trading, Massive Lock-up Expiry Countdown Continues to Weigh on Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1185699673","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185699673?lang=en_us&edition=fundamental","pubTime":"2026-06-10 10:15","pubTimestamp":1781057701,"startTime":"0","endTime":"0","summary":"On June 10, Insilico Medicine fell 5.09% in regular trading, trading at HK$31.88/share, with trading volume of HK$30.32 million.On the news front, the company's cornerstone investors and employee...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128579425","title":"Movement Alert｜Insilico Medicine Falls 5.43% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Life Sciences Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1128579425","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128579425?lang=en_us&edition=fundamental","pubTime":"2026-06-09 11:26","pubTimestamp":1780975586,"startTime":"0","endTime":"0","summary":"On June 9, Insilico Medicine fell 5.43% in regular trading, trading at 33.92 HKD/share, with trading volume of 103 million HKD.On the news front, the company's cornerstone investors and employee...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124659105","title":"Movement Alert｜Insilico Medicine Falls 5.69% in Regular Trading, Massive Lock-up Expiry Approaching Amid Broad Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1124659105","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124659105?lang=en_us&edition=fundamental","pubTime":"2026-06-08 10:23","pubTimestamp":1780885412,"startTime":"0","endTime":"0","summary":"On June 8, Insilico Medicine fell 5.69% in regular trading, trading at 35.68 HKD/share, with trading volume of approximately 54.76 million HKD.On the news front, the company's cornerstone investors...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}